Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
12.016,00 GBX | +0,74% | -5,48% | +13,36% |
Bedrijfswaardering: AstraZeneca PLC
Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Marktkapitalisatie 1 | 132.173 | 131.259 | 182.034 | 209.442 | 209.268 | 243.054 | - | - |
Variatie | - | -0,69% | 38,68% | 15,06% | -0,08% | 16,14% | - | - |
Bedrijfswaarde 1 | 144.182 | 143.126 | 206.417 | 232.365 | 231.778 | 263.916 | 257.861 | 250.707 |
Variatie | - | -0,73% | 44,22% | 12,57% | -0,25% | 13,87% | -2,29% | -2,77% |
K/w-verhouding | 97,8x | 41x | 1.469x | 64,1x | 35,4x | 28,1x | 24,1x | 21,3x |
PBR-ratio | 9,99x | 8,4x | 4,24x | 5,65x | 5,39x | 5,78x | 5,23x | 4,6x |
PEG | - | 0x | -15,2x | 0x | 0,4x | 0,6x | 1,5x | 1,6x |
Marktkapitalisatie/omzet | 5,42x | 4,93x | 4,87x | 4,72x | 4,57x | 4,65x | 4,33x | 4,08x |
Bedrijfswaarde/omzet | 5,91x | 5,38x | 5,52x | 5,24x | 5,06x | 5,05x | 4,6x | 4,21x |
Bedrijfswaarde/EBITDA | 21,6x | 17,2x | 27,2x | 25,2x | 17,1x | 15,1x | 12,9x | 11,5x |
Bedrijfswaarde/EBIT | 22,4x | 19,5x | 20,8x | 17,4x | 15,9x | 15,6x | 13,5x | 12x |
Bedrijfswaarde/FCF | 72,5x | 37,3x | 42,4x | 26,7x | 25,8x | 33,4x | 21,6x | 18x |
FCF Yield | 1,38% | 2,68% | 2,36% | 3,75% | 3,88% | 3% | 4,64% | 5,56% |
Dividend per aandeel 2 | 2,8 | 2,8 | 2,87 | 2,9 | 2,9 | 3,098 | 3,264 | 3,405 |
Rendement | 2,78% | 2,8% | 2,44% | 2,15% | 2,15% | 1,98% | 2,08% | 2,17% |
WPA 2 | 1,03 | 2,44 | 0,08 | 2,11 | 3,81 | 5,582 | 6,493 | 7,366 |
Uitkeringspercentage | 272% | 115% | 3.588% | 137% | 76,1% | 55,5% | 50,3% | 46,2% |
Omzet 1 | 24.384 | 26.617 | 37.417 | 44.351 | 45.811 | 52.220 | 56.096 | 59.595 |
EBITDA 1 | 6.686 | 8.311 | 7.586 | 9.237 | 13.580 | 17.446 | 19.963 | 21.878 |
EBIT 1 | 6.436 | 7.340 | 9.928 | 13.350 | 14.534 | 16.942 | 19.094 | 20.909 |
Nettowinst (verlies) 1 | 1.335 | 3.196 | 112 | 3.288 | 5.961 | 8.667 | 10.208 | 11.385 |
Nettoschuld 1 | 12.009 | 11.867 | 24.383 | 22.923 | 22.510 | 20.862 | 14.806 | 7.653 |
Referentiekoers 2 | 100,75 | 99,99 | 117,51 | 135,16 | 135,02 | 156,78 | 156,78 | 156,78 |
Aantal aandelen (in duizend) | 1.311.913 | 1.312.660 | 1.549.159 | 1.549.528 | 1.549.926 | 1.550.287 | - | - |
Datum van publicatie | 14/02/20 | 11/02/21 | 10/02/22 | 9/02/23 | 8/02/24 | - | - | - |
K/w-verhouding, Gedetailleerde evolutie
Toevoegen aan een lijst 0 geselecteerde | K/w-verhouding | EV/omzet | Beurskap. / EBITDA | Dividendrendement (Y) | Kapi. ($) | |
---|---|---|---|---|---|---|
28.09x | 5.05x | 14.99x | +1.98% | 243 mld. | ||
59.56x | 18.45x | 44.86x | +0.56% | 832 mld. | ||
40.44x | 14.09x | 28.68x | +1.24% | 605 mld. | ||
22.5x | 4.58x | 12.96x | +2.83% | 398 mld. | ||
37.8x | 7.16x | 15.47x | +3.21% | 343 mld. | ||
15.45x | 4.91x | 11.25x | +2.65% | 294 mld. | ||
15.86x | 3.76x | 9.85x | +3.71% | 252 mld. | ||
21.48x | 4.95x | 12.54x | +3.26% | 234 mld. | ||
51.21x | 6.89x | 12.07x | +2.76% | 179 mld. | ||
21.49x | 3.69x | 10.08x | +5.69% | 166 mld. | ||
Gemiddelde | 31,39x | 7,35x | 17,27x | +2,79% | 354,59 mld. | |
Gewogen gemiddelde per kap. | 36,39x | 9,81x | 22,94x | +2,21% |